Pattern Genomics develops Daydreamer, a proprietary bioinformatics software platform designed to perform simultaneous pattern analysis of DNA sequences and to support large-scale molecular assay design. The company aims to reduce the time and cost of assay development by replacing ad hoc research with a general assay design process. Pattern Genomics plans to offer an assay design service to the diagnostics and pharmaceutical industries, CLIA laboratories, governments and foundations. Its platform targets customers that need scalable, data-driven assay development based on large-scale sequencing data. The company recently raised $150K in funding to advance its software and service offering. Pattern Genomics is based in Madison, Connecticut.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2013